Single-Molecule SERS Discrimination of Proline from Hydroxyproline Assisted by a Deep Learning Model
Yingqi Zhao1,2, Kuo Zhan1,2, Pei-Lin Xin1,2
1Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Aapistie 5 A, 90220 Oulu, Finland.
Nano Letters
|April 17, 2025
Summary
Researchers developed a novel method using a particle-in-pore sensor and AI to detect single-molecule hydroxylation, crucial for early disease diagnostics. This breakthrough achieves 96.6% accuracy in distinguishing proline and hydroxyproline, overcoming previous signal interference challenges.
Area of Science:
- Analytical Chemistry
- Biotechnology
- Artificial Intelligence in Medicine
Background:
- Detecting low-abundance hydroxylation is critical for early disease diagnostics and drug development.
- Existing single-molecule surface-enhanced Raman spectroscopy (SERS) methods face challenges with signal fluctuations and citrate interference.
Purpose of the Study:
- To develop a robust method for single-molecule discrimination of hydroxylation.
- To overcome signal interference and fluctuations in SERS analysis for hydroxylation detection.
Main Methods:
- Utilized a plasmonic particle-in-pore sensor for enhanced SERS signal acquisition.
- Employed an occurrence frequency histogram of single-molecule SERS spectra to extract spectral features.
- Applied a one-dimensional convolutional neural network (1D-CNN) model for hydroxylation discrimination.
Main Results:
- Successfully achieved single-molecule discrimination of proline and hydroxyproline using the 1D-CNN model with 96.6% accuracy.
- The histogram method effectively mitigated signal fluctuations and citrate interference, enabling clean signal generation for model training.
- Validated that the 1D-CNN model's extracted features directly corresponded to hydroxylation-induced spectral changes.
Conclusions:
- The integrated approach of particle-in-pore SERS, histograms, and 1D-CNN offers a powerful new tool for single-molecule hydroxylation detection.
- This method provides a significant advancement for early disease diagnostics and the development of targeted therapeutics.


